Quick Recall

Fenofibrate does not reduce CHD morbidity and mortality in patients with type 2 Diabetes Mellitus. Click the case history to learn the correct answer.

(Edited)
23 Votes

LikeAnswersShare
no answers yet
No answers yet!
To be the first one, click here

Diseases Related to Discussion